STAT3 and hepatocellular carcinoma: Furthermore, we blocked TLR9 with a TLR9 antagonist and found a significant decrease in STAT3 Tyr705 phosphorylation (Figure 2M), suggesting that TLR9 activation promotes STAT3 Tyr705 phosphorylation in HCC cells.